Circulation · 1993 · 197 citations · 16 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacodynamicsCardiovascular MedicineCardiovascular PharmacodynamicsCardiovascular PharmacologyMigraine PharmacotherapyVasoactive Drug TherapyVasoactive Medications5-Hydroxytryptamine 1A Receptor Agonists5-Hydroxytryptamine Receptor PharmacologyAcute Migraine TreatmentAgonist ActivityCoronary HemodynamicsHeart RateHemodynamic MonitoringMigraine Pharmacology
BACKGROUND: Sumatriptan (GR43175) is a selective 5-hydroxytryptamine (5HT1) receptor agonist effective in the acute treatment of migraine. Recent in vitro experiments suggest that it has vasoactive properties in vascular beds distinct from the cerebral circulation. The object of this study was to assess the vasoactive effects of the standard 6-mg subcutaneous dose of sumatriptan used in migraine on the systemic and pulmonary circulations and the coronary artery vasculature. METHODS AND RESULTS: Ten patients undergoing diagnostic coronary arteriography were studied with digital subtraction angiography and invasive hemodynamic monitoring. After subcutaneous injection of sumatriptan, there was no significant change in heart rate or ECG morphology. There was a significant rise in the systemic (20%, p < 0.05 by ANOVA) and pulmonary artery (40%, p < 0.05 by ANOVA) pressures. There was no change in cardiac output, but there was a significant increase in total systemic (27%, p < 0.05) and total pulmonary vascular resistance (40%, p < 0.05). Sumatriptan caused a significant reduction (p < 0.001 by ANOVA) in mean absolute coronary artery diameter, from 4.36 +/- 1.60 mm at baseline to 3.67 +/- 1.49 mm (16%) at 10 minutes and to 3.63 +/- 1.49 mm (17%) at 30 minutes after injection. There were no clinical sequelae. CONCLUSIONS: Sumatriptan, a 5HT1 receptor agonist administered by the subcutaneous route, causes a vasopressor response in the systemic and pulmonary arterial circulations and coronary artery vasoconstriction.
16
Paolo Golino, Federico Piscione, James T. Willerson et al. · New England Journal of Medicine · 1991 · 423 citations · Full text
Medicine, Cardiology, Pharmacology +17
Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan
Lars Friberg, B Sperling, Jes Olesen et al. · The Lancet · 1991 · 373 citations
Medicine, Neurology, Neurosurgery +14